• Stem cell purification and transplantation emerged as the core cell-therapy paradigm, showing that highly purified hematopoietic stem cells can reconstitute all blood lineages from a small starting pool, enabling survival after lethal irradiation [1], [2], [19], [17].

• Immunological barriers to allogeneic marrow engraftment dominated early work, detailing GVHD, NK- and T-cell–mediated rejection, and minor histocompatibility effects; strategies included T-cell depletion and MHC-based tolerance approaches [3], [7], [15], [18], [11].

• Gene therapy in hematopoietic stem cells using retroviral vectors demonstrated long-term transgene expression and lympho-myelopoietic reconstitution in mice and primates, laying groundwork for somatic gene therapy in blood cells [8], [4], [5].

• Quantitative and functional dissection of stem cell populations advanced transplant biology, with methods to estimate transplantable primitive stem cells and track proliferative patterns across recipients [9], [1], [19].

• Immune-tolerance strategies using fractionated lymphoid irradiation and MHC/genetic approaches achieved long-term allograft survival and tolerance, illustrating controllable immune conditioning in transplantation [20], [11], [18].